Ozgene Pty Ltd
P.O. Box 1128
Ozgene is an Australian company that produces genetically modified (GM) mice and rats for global markets. GM mice and rats are currently the only animal models allowing researchers to precisely mimic human conditions of genetic disorders on a molecular level. GM mice and rats represent the most sophisticated and valuable tools in functional genomics and drug target validation.
Ozgene was founded in 1999 by Director and CEO Dr Frank Koentgen. Dr Koentgen has more than 15 years international experience in the management and production of GM mice and rats. He formerly established and headed the Genetically Modified Mouse Laboratory at the Walter and Eliza Hall Institute (WEHI) in Melbourne and previously provided GM mouse and rat services at Roche Pharmaceuticals. Ozgene's CEO is supported by an internationally experienced Board of Directors.
Ozgene's services include:
Custom design and construction of gene targeting and lentiviral transgenic vectors
Generation of knockout, knockin and humanised mice
Generation of lentiviral RNAi and transgenic mice and rats
Ozgene's global customer base includes individual academics, research institutes, biotechnology companies and multinational pharmaceutical companies from North America, Europe, Japan, Australia, and New Zealand.
Ozgene has strategic R&D partnerships with Bionomics Ltd, Adelaide, Australia and Tranzyme Inc, Alabama, USA. Ozgene produces all GM mice and rats to SPF standards in alliance with the Animal Resources Centre, Western Australia.
Last Updated: 05-10-04
Ozgene Pty Ltd